Patrick Frost, PhD

Patrick Frost, PhD

Jan 13, 2016

Group 6 Copy 44
-1
    Please wait...

    About This Project

    BBRI and Los Angeles VA Medical Center

    Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Using energy dispersive x-ray spectroscopy to characterize the proboscis of mosquitoes

    We hypothesize that female mosquitoes optimize their proboscis strength and flexibility for nectarivory...

    Conservation Efforts to Protect Endangered Turtles of Sulawesi

    Sulawesi, Indonesia, is home to many species found nowhere else on Earth. Although rich in biodiversity...

    Backer Badge Funded